 | • レポートコード：QYR2104Z5233 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、鎌状赤血球のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（病院、診療所、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・鎌状赤血球の市場動向 ・企業の競争状況、市場シェア ・鎌状赤血球の種類別市場規模（診断、治療） ・鎌状赤血球の用途別市場規模（病院、診療所、外来手術センター） ・鎌状赤血球の北米市場規模2016-2027（アメリカ、カナダ） ・鎌状赤血球のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・鎌状赤血球のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・鎌状赤血球の中南米市場規模2016-2027（メキシコ、ブラジル） ・鎌状赤血球の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、Bristol-Myers Squibb、Takeda、Bluebird Bio、Global Blood Therapeutics） ・結論 |
The global sickle cell market is expected to grow in future due to rising African-American population, economic growth, increasing healthcare expenditure and prevalence of sickle cell. Key trends of this market include progressing drug pipeline and rising research grants. However, there are some factors which can hinder growth of the market including regulatory changes, associated risks and slow adoption of treatments.
The U.S. is expected to be the first region to start the selling of sickle cell drugs due to developing drug therapies and later on, market penetration of sickle cell drugs would occur in Europe.
Market Analysis and Insights: Global Sickle Cell Market
The global Sickle Cell market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sickle Cell market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sickle Cell market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sickle Cell market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sickle Cell market.
Global Sickle Cell Scope and Market Size
Sickle Cell market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sickle Cell market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Diagnosis
Treatment
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novartis
Bristol-Myers Squibb
Takeda
Bluebird Bio
Global Blood Therapeutics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnosis
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Sickle Cell Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Market Perspective (2016-2027)
2.2 Sickle Cell Growth Trends by Regions
2.2.1 Sickle Cell Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sickle Cell Historic Market Share by Regions (2016-2021)
2.2.3 Sickle Cell Forecasted Market Size by Regions (2022-2027)
2.3 Sickle Cell Industry Dynamic
2.3.1 Sickle Cell Market Trends
2.3.2 Sickle Cell Market Drivers
2.3.3 Sickle Cell Market Challenges
2.3.4 Sickle Cell Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sickle Cell Players by Revenue
3.1.1 Global Top Sickle Cell Players by Revenue (2016-2021)
3.1.2 Global Sickle Cell Revenue Market Share by Players (2016-2021)
3.2 Global Sickle Cell Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sickle Cell Revenue
3.4 Global Sickle Cell Market Concentration Ratio
3.4.1 Global Sickle Cell Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Revenue in 2020
3.5 Sickle Cell Key Players Head office and Area Served
3.6 Key Players Sickle Cell Product Solution and Service
3.7 Date of Enter into Sickle Cell Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle Cell Breakdown Data by Type
4.1 Global Sickle Cell Historic Market Size by Type (2016-2021)
4.2 Global Sickle Cell Forecasted Market Size by Type (2022-2027)
5 Sickle Cell Breakdown Data by Application
5.1 Global Sickle Cell Historic Market Size by Application (2016-2021)
5.2 Global Sickle Cell Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Sickle Cell Market Size (2016-2027)
6.2 North America Sickle Cell Market Size by Type
6.2.1 North America Sickle Cell Market Size by Type (2016-2021)
6.2.2 North America Sickle Cell Market Size by Type (2022-2027)
6.2.3 North America Sickle Cell Market Size by Type (2016-2027)
6.3 North America Sickle Cell Market Size by Application
6.3.1 North America Sickle Cell Market Size by Application (2016-2021)
6.3.2 North America Sickle Cell Market Size by Application (2022-2027)
6.3.3 North America Sickle Cell Market Size by Application (2016-2027)
6.4 North America Sickle Cell Market Size by Country
6.4.1 North America Sickle Cell Market Size by Country (2016-2021)
6.4.2 North America Sickle Cell Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Sickle Cell Market Size (2016-2027)
7.2 Europe Sickle Cell Market Size by Type
7.2.1 Europe Sickle Cell Market Size by Type (2016-2021)
7.2.2 Europe Sickle Cell Market Size by Type (2022-2027)
7.2.3 Europe Sickle Cell Market Size by Type (2016-2027)
7.3 Europe Sickle Cell Market Size by Application
7.3.1 Europe Sickle Cell Market Size by Application (2016-2021)
7.3.2 Europe Sickle Cell Market Size by Application (2022-2027)
7.3.3 Europe Sickle Cell Market Size by Application (2016-2027)
7.4 Europe Sickle Cell Market Size by Country
7.4.1 Europe Sickle Cell Market Size by Country (2016-2021)
7.4.2 Europe Sickle Cell Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Sickle Cell Market Size (2016-2027)
8.2 Asia-Pacific Sickle Cell Market Size by Type
8.2.1 Asia-Pacific Sickle Cell Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sickle Cell Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sickle Cell Market Size by Type (2016-2027)
8.3 Asia-Pacific Sickle Cell Market Size by Application
8.3.1 Asia-Pacific Sickle Cell Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Sickle Cell Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Sickle Cell Market Size by Application (2016-2027)
8.4 Asia-Pacific Sickle Cell Market Size by Region
8.4.1 Asia-Pacific Sickle Cell Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sickle Cell Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Sickle Cell Market Size (2016-2027)
9.2 Latin America Sickle Cell Market Size by Type
9.2.1 Latin America Sickle Cell Market Size by Type (2016-2021)
9.2.2 Latin America Sickle Cell Market Size by Type (2022-2027)
9.2.3 Latin America Sickle Cell Market Size by Type (2016-2027)
9.3 Latin America Sickle Cell Market Size by Application
9.3.1 Latin America Sickle Cell Market Size by Application (2016-2021)
9.3.2 Latin America Sickle Cell Market Size by Application (2022-2027)
9.3.3 Latin America Sickle Cell Market Size by Application (2016-2027)
9.4 Latin America Sickle Cell Market Size by Country
9.4.1 Latin America Sickle Cell Market Size by Country (2016-2021)
9.4.2 Latin America Sickle Cell Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sickle Cell Market Size (2016-2027)
10.2 Middle East & Africa Sickle Cell Market Size by Type
10.2.1 Middle East & Africa Sickle Cell Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sickle Cell Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sickle Cell Market Size by Type (2016-2027)
10.3 Middle East & Africa Sickle Cell Market Size by Application
10.3.1 Middle East & Africa Sickle Cell Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Sickle Cell Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Sickle Cell Market Size by Application (2016-2027)
10.4 Middle East & Africa Sickle Cell Market Size by Country
10.4.1 Middle East & Africa Sickle Cell Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sickle Cell Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Sickle Cell Introduction
11.1.4 Novartis Revenue in Sickle Cell Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Sickle Cell Introduction
11.2.4 Bristol-Myers Squibb Revenue in Sickle Cell Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Sickle Cell Introduction
11.3.4 Takeda Revenue in Sickle Cell Business (2016-2021)
11.3.5 Takeda Recent Development
11.4 Bluebird Bio
11.4.1 Bluebird Bio Company Details
11.4.2 Bluebird Bio Business Overview
11.4.3 Bluebird Bio Sickle Cell Introduction
11.4.4 Bluebird Bio Revenue in Sickle Cell Business (2016-2021)
11.4.5 Bluebird Bio Recent Development
11.5 Global Blood Therapeutics
11.5.1 Global Blood Therapeutics Company Details
11.5.2 Global Blood Therapeutics Business Overview
11.5.3 Global Blood Therapeutics Sickle Cell Introduction
11.5.4 Global Blood Therapeutics Revenue in Sickle Cell Business (2016-2021)
11.5.5 Global Blood Therapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Sickle Cell Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diagnosis
Table 3. Key Players of Treatment
Table 4. Global Sickle Cell Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Sickle Cell Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Sickle Cell Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Sickle Cell Market Share by Regions (2016-2021)
Table 8. Global Sickle Cell Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Sickle Cell Market Share by Regions (2022-2027)
Table 10. Sickle Cell Market Trends
Table 11. Sickle Cell Market Drivers
Table 12. Sickle Cell Market Challenges
Table 13. Sickle Cell Market Restraints
Table 14. Global Sickle Cell Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Sickle Cell Market Share by Players (2016-2021)
Table 16. Global Top Sickle Cell Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell as of 2020)
Table 17. Ranking of Global Top Sickle Cell Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Sickle Cell Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Sickle Cell Product Solution and Service
Table 21. Date of Enter into Sickle Cell Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sickle Cell Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Sickle Cell Revenue Market Share by Type (2016-2021)
Table 25. Global Sickle Cell Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Sickle Cell Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Sickle Cell Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Sickle Cell Revenue Market Share by Application (2016-2021)
Table 29. Global Sickle Cell Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Sickle Cell Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Sickle Cell Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Sickle Cell Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Sickle Cell Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Sickle Cell Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Sickle Cell Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Sickle Cell Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Sickle Cell Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Sickle Cell Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Sickle Cell Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Sickle Cell Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Sickle Cell Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Sickle Cell Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Sickle Cell Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Sickle Cell Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Sickle Cell Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Sickle Cell Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Sickle Cell Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Sickle Cell Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Sickle Cell Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Sickle Cell Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Sickle Cell Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Sickle Cell Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Sickle Cell Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Sickle Cell Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Sickle Cell Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Sickle Cell Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Sickle Cell Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Sickle Cell Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Sickle Cell Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Sickle Cell Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Sickle Cell Product
Table 64. Novartis Revenue in Sickle Cell Business (2016-2021) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Bristol-Myers Squibb Company Details
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb Sickle Cell Product
Table 69. Bristol-Myers Squibb Revenue in Sickle Cell Business (2016-2021) & (US$ Million)
Table 70. Bristol-Myers Squibb Recent Development
Table 71. Takeda Company Details
Table 72. Takeda Business Overview
Table 73. Takeda Sickle Cell Product
Table 74. Takeda Revenue in Sickle Cell Business (2016-2021) & (US$ Million)
Table 75. Takeda Recent Development
Table 76. Bluebird Bio Company Details
Table 77. Bluebird Bio Business Overview
Table 78. Bluebird Bio Sickle Cell Product
Table 79. Bluebird Bio Revenue in Sickle Cell Business (2016-2021) & (US$ Million)
Table 80. Bluebird Bio Recent Development
Table 81. Global Blood Therapeutics Company Details
Table 82. Global Blood Therapeutics Business Overview
Table 83. Global Blood Therapeutics Sickle Cell Product
Table 84. Global Blood Therapeutics Revenue in Sickle Cell Business (2016-2021) & (US$ Million)
Table 85. Global Blood Therapeutics Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sickle Cell Market Share by Type: 2020 VS 2027
Figure 2. Diagnosis Features
Figure 3. Treatment Features
Figure 4. Global Sickle Cell Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Sickle Cell Report Years Considered
Figure 9. Global Sickle Cell Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Sickle Cell Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Sickle Cell Market Share by Regions: 2020 VS 2027
Figure 12. Global Sickle Cell Market Share by Regions (2022-2027)
Figure 13. Global Sickle Cell Market Share by Players in 2020
Figure 14. Global Top Sickle Cell Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Sickle Cell Revenue in 2020
Figure 16. Global Sickle Cell Revenue Market Share by Type (2016-2021)
Figure 17. Global Sickle Cell Revenue Market Share by Type (2022-2027)
Figure 18. North America Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Sickle Cell Market Share by Type (2016-2027)
Figure 20. North America Sickle Cell Market Share by Application (2016-2027)
Figure 21. North America Sickle Cell Market Share by Country (2016-2027)
Figure 22. United States Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Sickle Cell Market Share by Type (2016-2027)
Figure 26. Europe Sickle Cell Market Share by Application (2016-2027)
Figure 27. Europe Sickle Cell Market Share by Country (2016-2027)
Figure 28. Germany Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Sickle Cell Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Sickle Cell Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Sickle Cell Market Share by Region (2016-2027)
Figure 38. China Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Sickle Cell Market Share by Type (2016-2027)
Figure 46. Latin America Sickle Cell Market Share by Application (2016-2027)
Figure 47. Latin America Sickle Cell Market Share by Country (2016-2027)
Figure 48. Mexico Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Sickle Cell Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Sickle Cell Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Sickle Cell Market Share by Country (2016-2027)
Figure 54. Turkey Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Sickle Cell Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Novartis Revenue Growth Rate in Sickle Cell Business (2016-2021)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Sickle Cell Business (2016-2021)
Figure 59. Takeda Revenue Growth Rate in Sickle Cell Business (2016-2021)
Figure 60. Bluebird Bio Revenue Growth Rate in Sickle Cell Business (2016-2021)
Figure 61. Global Blood Therapeutics Revenue Growth Rate in Sickle Cell Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
世界の鎌状赤血球症治療市場規模・現状・予測（2021年-2027年） Sickle cell disease is a group of disorders that affects hemoglobin, the molecule in red blood cells that delivers oxygen to cells throughout the body. People with this disorderhave atypical hemoglobin molecules called hemoglobin S, which can distort red blood cells into a sickle, or crescent, shape…- 世界の鎌状赤血球貧血治療薬市場規模・現状・予測（2021年-2027年） Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…
- 世界の鎌状赤血球症治療市場規模・現状・予測（2021年-2027年） Sickle Cell Disease (SCD) is a group of blood disorders typically inherited from a person's parents. The care of people with sickle cell disease may include infection prevention with vaccination and antibiotics, high fluid intake, folic acid supplementation and pain medication. Market Analysis and I…
- 世界の鎌状赤血球貧血治療薬市場規模・現状・予測（2021年-2027年） Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…
- 世界の鎌状赤血球症治療市場 2021：企業別、地域別、種類・用途別 The Sickle Cell Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…